Cleared Traditional

PhysCade System (K250749) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K250749 · Physcade, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
84d
Days
Class 2
Risk

K250749 is an FDA 510(k) clearance for the PhysCade System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Physcade, Inc. (Palo Alto, US). The FDA issued a Cleared decision on June 4, 2025 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Physcade, Inc. devices

Submission Details

510(k) Number K250749 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 2025
Decision Date June 04, 2025
Days to Decision 84 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 125d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 189
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K250749.
EnSite™ X EP System
K251234 · Abbott Medical · Jul 2025
HemoSphere Advanced Monitor (HEM1)
K243781 · Edwards Lifesciences · Jul 2025
Globe® Pulsed Field System
K250747 · Kardium, Inc. · Jun 2025
OptiMap™ System
K251344 · Boston Scientific Corporation · May 2025
DeepRhythmAI
K250932 · Medicalgorithmics S.A. · May 2025
Volta AF-Xplorer
K243812 · Volta Medical · May 2025